EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Objective: to investigate the efficacy of an anti-BlyS drug (belimumab) for the treatment of systemic lupus erythematous (SLE).Subjects and methods. Belimumab (BLM) was administered to three patients with SLE (two women and one man were aged 24, 28, and 39 years, respectively). SLE activity was esti...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Aseeva, S. K. Soloviev, A. A. Mesnyankina, M. E. Tsanyan, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2015-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2098
Tags: Add Tag
No Tags, Be the first to tag this record!